Business Description
PaxMedica Inc
NAICS : 541714
SIC : 2833
ISIN : US70424C2035
Share Class Description:
PXMD: Ordinary SharesDescription
PaxMedica Inc is a clinical-stage biopharmaceutical company focusing on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms, ranging from neurodevelopmental disorders, including autism spectrum disorder (ASD), to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), a debilitating physical and cognitive disorder believed to be viral in origin and now with rising incidence globally due to the long term effects of SARS-CoV-2 (COVID-19). The company's product candidate under development is PAX-101, an intravenous formulation of suramin, which it is developing for multiple indications, including East African HAT, ASD, ME/CFS, and LCS.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.98 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | -0.09 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 3.6 | |||||
| 3-Year EPS without NRI Growth Rate | 5.7 | |||||
| 3-Year FCF Growth Rate | -17.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 59.62 | |||||
| 9-Day RSI | 58.51 | |||||
| 14-Day RSI | 57.17 | |||||
| 6-1 Month Momentum % | -86.28 | |||||
| 12-1 Month Momentum % | -98.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.16 | |||||
| Quick Ratio | 3.16 | |||||
| Cash Ratio | 2.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -157.9 | |||||
| Shareholder Yield % | -232.35 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -1179.17 | |||||
| ROA % | -435.16 | |||||
| ROIC % | -1329.98 | |||||
| ROC (Joel Greenblatt) % | -3151.72 | |||||
| ROCE % | -949.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.63 | |||||
| Price-to-Tangible-Book | 1.63 | |||||
| EV-to-EBIT | -0.33 | |||||
| EV-to-EBITDA | -0.33 | |||||
| EV-to-FCF | -0.55 | |||||
| Price-to-Net-Current-Asset-Value | 1.63 | |||||
| Price-to-Net-Cash | 2.27 | |||||
| Earnings Yield (Greenblatt) % | -303.03 | |||||
| FCF Yield % | -192.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PXMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PaxMedica Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -15.178 | ||
| Beta | 0 | ||
| Volatility % | 75.17 | ||
| 14-Day RSI | 57.17 | ||
| 14-Day ATR ($) | 0.113811 | ||
| 20-Day SMA ($) | 0.626178 | ||
| 12-1 Month Momentum % | -98.13 | ||
| 52-Week Range ($) | 0.372 - 29.75 | ||
| Shares Outstanding (Mil) | 7.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PaxMedica Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PaxMedica Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
PaxMedica Inc Frequently Asked Questions
What is PaxMedica Inc(PXMD)'s stock price today?
The current price of PXMD is $0.75. The 52 week high of PXMD is $29.75 and 52 week low is $0.37.
When is next earnings date of PaxMedica Inc(PXMD)?
The next earnings date of PaxMedica Inc(PXMD) is 2024-05-31 Est..
Does PaxMedica Inc(PXMD) pay dividends? If so, how much?
PaxMedica Inc(PXMD) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers